Q2 2022 Aarti Drugs Ltd Earnings Call Transcript
Ladies and gentlemen, good day and welcome to Aarti Drugs Limited, Q2 FY22 earnings conference call. This conference call may contain forward-looking statements about the company, which are based on the beliefs, opinions, and expectations of the company as on the date of this call.
These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Adhish Patil, CFO, Aarti Drugs Limited. Thank you and over to you, sir.
Thank you. Good afternoon everyone, and season's greetings to all of you present on the call to discuss our financial results for Q2 and H1 FY22. Aarti Drugs delivered a resilient performance despite continuous input cost pressures.
Before I take you through the performance highlight, let me remind you that as communicated in the earlier earnings call, the financial performance on a year-on-year basis is not exactly
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
